B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes

International Journal of Cancer

Volumn 130, Issue 10, 2012, Pages 2282-2290

  Tekle, Christina ^a   Nygren, Marit Kveine ^a   Chen, Yih Wen ^b   Dybsjord, Indrejit ^a   Nesland, Jahn Marthin ^a,c   Mælandsmo, Gunhild Mari ^a,d   Fodstad, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

B7 H3; invasion; melanoma; metastasis; therapeutic target

Indexed keywords

GELATINASE A; INTERLEUKIN 8; MEMBRANE PROTEIN; PROTEIN B7 H3; SHORT HAIRPIN RNA; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE SILENCING; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ANIMALS; B7 ANTIGENS; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RATS; RNA, SMALL INTERFERING; SKIN NEOPLASMS;

EID: 84859099360     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26238     Document Type: Article

References (48)

1. Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, Sementa AR, Negri F, Conte R, Corrias MV, Moretta L, Moretta A, Bottino C,. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 2004; 101: 12640-5. (Pubitemid 39122076)
2. Sun M, Richards S, Prasad DV, Mai XM, Rudensky A, Dong C,. Characterization of mouse and human B7-H3 genes. J Immunol 2002; 168: 6294-7. (Pubitemid 34620050)
3. Flies DB, Chen L,. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007; 30: 251-60. (Pubitemid 46586641)
4. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L,. B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2: 269-74. (Pubitemid 33706005)
5. Leitner J, Klauser C, Pickl WF, Stockl J, Majdic O, Bardet AF, Kreil DP, Dong C, Yamazaki T, Zlabinger G, Pfistershammer K, Steinberger P,. B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction. Eur J Immunol 2009; 39: 1754-64.
6. Arigami T, Narita N, Mizuno R, Nguyen L, Ye X, Chung A, Giuliano AE, Hoon DS,. B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg; 252: 1044-51.
7. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED,. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 2008; 14: 5150-7.
8. Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, Tan Y, Wang HT, Lu BF, Zhang XG,. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 2010; 59: 1163-71.
9. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X,. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006; 53: 143-51. (Pubitemid 43994236)
10. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y,. Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 2009; 101: 1709-16.
11. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, Allison JP,. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 2007; 104: 19458-63.
12. Loos M, Hedderich DM, Ottenhausen M, Giese NA, Laschinger M, Esposito I, Kleeff J, Friess H,. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 2009; 9: 463.
13. Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF, Zhao JM, Zhang GB, Zhang XG,. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 2006; 12: 457-9. (Pubitemid 43329266)
14. Chen YW, Tekle C, Fodstad O,. The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Tar 2008; 8: 404-13.
15. Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Maelandsmo GM, Nesland JM, Fodstad O, et al., B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther 2011; 10: 960-71.
16. Fidler IJ,. Critical factors in the biology of human cancer metastasis: twenty-eighth GHA. Clowes memorial award lecture. Cancer Res 1990; 50: 6130-8. (Pubitemid 20323663)
17. Steeg PS, Theodorescu D,. Metastasis: a therapeutic target for cancer. Nat Clin Pract 2008; 5: 206-19. (Pubitemid 351493680)
18. Fidler IJ, Poste G,. The "seed and soil" hypothesis revisited. Lancet Oncol 2008; 9: 808.
19. Paget S,. The distribution of secondary growths in cancer of the breast. Cancer Metastas Rev 1889; 8: 98-101.
20. Brown TJ, Nelson BR,. Malignant melanoma: a clinical review. Cutis: Cut Med Pract 1999; 63: 275-8, 81-4.
21. Fodstad O, Kjonniksen I, Aamdal S, Nesland JM, Boyd MR, Pihl A,. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res 1988; 48: 4382-8.
22. Kjonniksen I, Rye PD, Fodstad O,. Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice. Br J Cancer 1994; 69: 1021-4. (Pubitemid 24161852)
23. Aamdal S, Fodstad O, Pihl A,. Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response. Int J Cancer 1984; 34: 725-30. (Pubitemid 15207016)
24. Kjonniksen I, Nesland JM, Pihl A, Fodstad O,. Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. J Natl Cancer Inst 1990; 82: 408-12. (Pubitemid 20108033)
25. Prasmickaite L, Engesaeter BO, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM,. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PloS One; 5: e10731.
26. Zbytek B, Carlson JA, Granese J, Ross J, Mihm MC, Slominski A,. Current concepts of metastasis in melanoma. Exp Rev Dermat 2008; 3: 569-85.
27. Kortylewski M, Jove R, Yu H,. Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastas Rev 2005; 24: 315-27. (Pubitemid 40922802)
28. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ,. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242-7. (Pubitemid 24208936)
29. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, et al., B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res 2007; 67: 7893-900. (Pubitemid 47281385)
30. Zang X, Loke P, Kim J, Murphy K, Waitz R, Allison JP,. B7x: A widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003; 100: 10388-92. (Pubitemid 37071888)
31. Quandt D, Fiedler E, Boettcher D, Marsch W, Seliger B,. B7-H4 expression in human melanoma: its association with patients' survival and anti tumor immune response. Clin Cancer Res 2011; 17: 3100-11.
32. Shapiro SD,. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10: 602-8. (Pubitemid 28477018)
33. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP,. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111-22. (Pubitemid 27455388)
34. Waugh DJ, Wilson C,. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735-41.
35. Singh RK, Varney ML,. IL-8 expression in malignant melanoma: implications in growth and metastasis. Histol Histopathol 2000; 15: 843-9. (Pubitemid 30488567)
36. Messina JL, Yu H, Riker AI, Munster PN, Jove RL, Daud AI,. Activated stat-3 in melanoma. Cancer Control 2008; 15: 196-201.
37. Welch DR,. Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastas 1997; 15: 272-306. (Pubitemid 27240358)
38. Fidler IJ,. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev 2003; 3: 453-8. (Pubitemid 37328849)
39. Fodstad O, Kjonniksen I,. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J Cell Biochem 1994; 56: 23-8. (Pubitemid 24288106)
40. Cailleau R, Olive M, Cruciger QV,. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In vitro 1978; 14: 911-5. (Pubitemid 9089089)
41. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, et al., Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24: 227-35. (Pubitemid 30132189)
42. Harms JF, Welch DR,. MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastas 2003; 20: 327-34. (Pubitemid 36745661)
43. McWilliams RR, Rao RD, Buckner JC, Link MJ, Markovic S, Brown PD,. Melanoma-induced brain metastases. Expert review of anticancer therapy 2008; 8: 743-55.
44. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S,. Activation of stat3 in human melanoma promotes brain metastasis. Cancer research 2006; 66: 3188-96.
45. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M,. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. The American journal of pathology 1997; 151: 1105-13. (Pubitemid 27424320)
46. Oka M, Sakaguchi M, Okada T, Nagai H, Ozaki M, Yoshioka T, Inoue H, Mukaida N, Kikkawa U, Nishigori C,. Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells. Experimental dermatology 2010; 19: e50-5.
47. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S,. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004; 23: 3550-60. (Pubitemid 38658421)
48. Xu H, Cheung IY, Guo HF, Cheung NK,. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer research 2009; 69: 6275-81.